Thomson Reuters reports that global M&A stands at $4.2 billion, besting the previous top of $4.1 billion from 2007 (i.e., just before the financial crisis). It is only the second time in history that there has been more than $4 billion in M&A activity, and the threshold was crossed earlier in 2015 than in 2007. Moreover, 2015 also has played host to a record-breaking number of deals valued at $5 billion or more.
It also is worth noting that the Pfizer/Allergan combination would be the second-largest merger on record, following Vodafone Airtouch’s $202.8 billion purchase of Mannesmann in 1999. It also helps further obliterate existing pharma and healthcare M&A stats:
Get Term Sheet, our daily newsletter on deals & deal-makers.